Examines GUCY2C-targeted pharmacotherapy effectiveness in colorectal cancer, suggesting potential therapeutic benefits.
No takes yet. Share an insight, caveat, or question.
Waldman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: